Successful replacement of systemic immunosuppression by local graft irradiation in the management of listeria meningitis

2003 ◽  
Vol 35 (4) ◽  
pp. 1322-1323
Author(s):  
R.E Power ◽  
D.M Little ◽  
E Smyth ◽  
E McNamara ◽  
D.P Hickey
2012 ◽  
Vol 2012 ◽  
pp. 1-5 ◽  
Author(s):  
M. Krakauer ◽  
J. D. Welder ◽  
H. K. Pandya ◽  
N. Nassiri ◽  
A. R. Djalilian

Purpose. Keratolimbal allograft (KLAL) is a treatment for limbal stem cell deficiency. One disadvantage is systemic immunosuppression to avoid rejection. Our purpose was to examine the adverse effects of systemic immunosuppression in KLAL.Methods. A retrospective case review of 16 patients with KLAL who received systemic immunosuppression consisting of a corticosteroid, an antimetabolite, and/or a calcineurin inhibitor was performed. Patients were monitored for signs, symptoms, or laboratory evidence of toxicity.Results. Twelve of 16 patients (75%) experienced an adverse effect. The average age of those with adverse effects was 50.0 years (SD 17.8) and those without was 23.6 years (SD: 14.3), which was statistically significant (unpairedt-testP=0.022). Ten of 11 patients (91%) had resolution during mean followup of 16.4 months. No serious adverse effects occurred. The most common included anemia, hyperglycemia, elevated creatinine, and elevated liver function tests. Prednisone and tacrolimus were responsible for the most adverse effects. More patients with comorbidities experienced adverse effects (83%) than those without comorbidities (25%).Conclusions. KLAL requires prolonged systemic immunosuppression. Our data demonstrated that systemic immunosuppression did not result in serious adverse effects in our population and is relatively safe with monitoring for toxicity. In addition, we demonstrated that adverse effects occurred more frequently in older patients and those with comorbidities.


2003 ◽  
Vol 76 (1) ◽  
pp. 263-264 ◽  
Author(s):  
Christoph Schmid ◽  
Rahel Naef ◽  
Rudolf Speich ◽  
Annette Boehler

2008 ◽  
Vol 47 (12) ◽  
pp. 1129-1131 ◽  
Author(s):  
Kohei Fujita ◽  
Tomotaka Tanaka ◽  
Syoichiro Kono ◽  
Hisashi Narai ◽  
Nobuhiko Omori ◽  
...  

2021 ◽  
Vol 62 (1) ◽  
pp. 155-175
Author(s):  
Alexandria L. Chaulk ◽  
Chase Miller ◽  
Matthew Barke ◽  
Baruch Goldberg ◽  
Alla Goldberg

2021 ◽  
Vol 51 (12) ◽  
pp. 2149-2150
Author(s):  
Terri Shih ◽  
Shawn Shih ◽  
Mohammad Sharaf

PEDIATRICS ◽  
1955 ◽  
Vol 16 (4) ◽  
pp. 500-503
Author(s):  
Bernard Selinger ◽  
Frederick P. Becker

A case of Listeria monocytogenes meningitis in the neonatal period, diagnosed primarily by blood culture, is presented. Recovery was uneventful. The organism showed in-vitro sensitivity to erythromycin, oxytetracycline, chlortetracycline, and penicillin, and was resistant to several sulfornamide compounds.


Stroke ◽  
2015 ◽  
Vol 46 (suppl_1) ◽  
Author(s):  
Swarna Rajagopalan ◽  
Richard Ronca ◽  
Ausim Azizi

INTRODUCTION: Infection is a significant cause of mortality in patients with both ischemic and hemorrhagic stroke. This is thought to occur as a result of stroke-induced systemic immunosuppression (SIIS). The role of cerebral damage pre-disposing to sepsis has only been addressed in a few studies for ischemic stroke, and literature is sparse in Spontaneous Intracerebral Hemorrhage (SICH) patients who have higher mortality, greater disability and require more intensive medical care. We sought to determine identify predictors of SIIS and sepsis, so we may be able to recognize and intervene early. METHODOLOGY: We retrospectively analyzed 40 patients with SICH admitted to the NICU between January 2012 and January 30, 2014. We included patients with SICH. We excluded patients with multi-compartmental hemorrhage and patients lacking outcome data. Patient demographics including age, gender, location, volume of SICH, GCS, and total lymphocyte counts from days one to five of hospitalization was recorded. Data was divided into a non-infection group, where patients lacked any clinical or laboratory evidence of infections, and an infection group. Statistical analysis was performed to compare lymphocyte depletion over time between patients that developed an infection and those that did not. RESULTS: From the cohort of 40 patients with SICH, 20 developed an infection during their hospital course. Total lymphocyte counts were lower on all five days in the infection group compared to the non-infection group and became significant on day four of hospitalization (1 in the infection group vs. 2.1 in the non-infection group, p<0.01. Lymphopenia preceded clinical signs and symptoms of infection, which occurred in average on day 5.8 of hospitalization. Patients in the infection group had greater hemorrhage volume (32.5 ml vs. 15.5 ml) and poorer GCS scores on admission (12.7 vs. 11.8) although these differences did not reach statistical significance. CONCLUSION: The incidence of sepsis is high in SICH patients, and these patients have worse prognostic parameters. Our data suggests identification of lymphopenia may be a significant predictor of development of clinical infection in these patients. Future studies with larger sample sizes are warranted.


2021 ◽  
Vol 134 (1) ◽  
pp. e64-e65
Author(s):  
Naomi Hauser ◽  
Paul M. Luethy ◽  
Nicholas Stamatos
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document